BOSTON SCIENTIFIC CORP
Boston Scientific Corporation is a medical device company that filed an amended Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The amendment was made to include the executed copy of the consent of independent registered public accounting firm, Ernst & Young LLP, with the conformed electronic signature. The company is an accelerated filer and its common stock is traded on the New York Stock Exchange under the ticker symbol BSX. The aggregate market value of the registrant’s common stock held by non-affiliates was approximately $ billion based on the last reported sale price of $54.09 on June 30, 2023. The number of shares outstanding of Common Stock was as of January 31, 2024. There were no changes to the Form 10-K or the consent. Boston Scientific Corporation is engaged in developing, manufacturing, and marketing medical devices and therapeutic products. The company's portfolio includes interventional cardiology, rhythm management, neuromodulation, endoscopy, and urology and pelvic health. For more information, visit the company's website at www.bostonscientific.com.